Related Experiment Videos
[New treatments of hemoglobinopathies]
1Centre de Transfusion sanguine, Hôpital Necker-Enfants malades, Paris.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Transfusing children with hemoglobinopathies.
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2019
Management of iron overload in hemoglobinopathies.
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2017
[Cerebral vasculopathy in pediatric sickle-cell anemia].
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2014
Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.
Presse medicale (Paris, France : 1983)·2026
Artificial intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.
Presse medicale (Paris, France : 1983)·2026
AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.
Presse medicale (Paris, France : 1983)·2026
Artificial Intelligence in medical research and publishing: Progress, risks, and future perspectives.
Presse medicale (Paris, France : 1983)·2026
Ethical, legal, and regulatory challenges in AI-based healthcare tools.
Presse medicale (Paris, France : 1983)·2026
Beyond one-size-fits-all: Personalising health communication to drive real behaviour change.
Presse medicale (Paris, France : 1983)·2026
Transforming Hemophilia Treatment With Novel Rebalancing Agents: Clinical Studies and Practical Perspectives.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Targeting Thrombopoietin/MPL Signaling to Mitigate JAK2V617F-Driven Cardiac Microvascular Disease.
Arteriosclerosis, thrombosis, and vascular biology·2026
Machine Learning-Based Prediction of Hemoglobin Variability in Patients with Chronic Kidney Disease Receiving Erythropoiesis-Stimulating Agents: A Real-World Retrospective Study.
International journal of nephrology and renovascular disease·2026